Latest filing published 02 Apr 2026 for Maze Therapeutics, Inc., €22k.
Filing timeline
BuySaleInsider track record
Amy Bachrodt: trading record in brief
All filings by Amy Bachrodt on record concern Maze Therapeutics, Inc. Over a trading history stretching from 29 December 2025 to 1 April 2026, the count stands at 25 filings.
No open-market purchase appears, only 13 sales worth €1.3M. Other entries cover 12 option exercises. So far in 2026, the count stands at no purchases and 10 sales.
The latest filing, published on 2 April 2026, reports an option exercise of €22k in Maze Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Amy Bachrodt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$10.4211.3% of flowCommon StockSEC:0002050422-26-000012:0
- 2,200 shares@ US$29.322728.1% of flowCommon StockSEC:0002050422-26-000012:1
- 300 shares@ US$30.33674.0% of flowCommon StockSEC:0002050422-26-000012:2
- 5,000 shares@ US$10.4222.4% of flowCommon StockSEC:0002050422-26-000010:0
- 4,844 shares@ US$10.4221.5% of flowCommon StockSEC:0002050422-26-000008:0
- 2,497 shares@ US$10.4211.3% of flowCommon StockSEC:0002050422-26-000005:0
- 204 shares@ US$10.420.9% of flowCommon StockSEC:0002050422-26-000003:0
- 124 shares@ US$10.420.6% of flowCommon StockSEC:0002050422-25-000007:0
8 of 8 declarations
